Brian Patrick Tullius MD
Pediatric Hematologic Oncology
Research Medical Director for Pediatric Cellular Therapies
2501 N Orange AveSuite 581Orlando, FL 32804
Overview of Dr. Tullius
Brian Tullius, MD, based in Orlando, FL, is a specialist in Pediatric Hematology & Oncology with subspecialties in Pediatric Hematologic Oncology. He completed his pediatrics residency at the University of California Davis Health and internships and fellowships in pediatrics and pediatric hematology/oncology at the Naval Medical Center and Nationwide Children's Hospital/Ohio State University, among others. Currently, he is the Research Medical Director at AdventHealth for Children. Dr. Tullius has authored several notable publications on topics such as cancer immunotherapy and NK cells, with significant citations. He has actively contributed to a clinical trial on NK cell infusions for high-risk acute myeloid leukemia in children and young adults.
Education & Training
Nationwide Children's Hospital/Ohio State UniversityFellowship, Pediatric Hematology/Oncology, 2020 - 2021- Nationwide Children's Hospital/Ohio State UniversityFellowship, Pediatric Hematology/Oncology, 2017 - 2020
University of California Davis HealthResidency, Pediatrics, 2014 - 2017
Naval Aerospace Medical InstituteFlight Surgeon, 2009 - 2010
Naval Medical Center (San Diego)Internship, Pediatrics, 2008 - 2009
Certifications & Licensure
FL State Medical License 2021 - 2027
OH State Medical License 2017 - 2021
CA State Medical License 2015 - 2019
NE State Medical License 2010 - 2014
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
Publications & Presentations
PubMed
- 28 citationsKnockout of the inhibitory receptor TIGIT enhances the antitumor response of ex vivo expanded NK cells and prevents fratricide with therapeutic Fc-active TIGIT antibod...Md Faqrul Hasan, Amanda R Campbell, Tayler J Croom-Perez, Jeremiah L Oyer, Thomas A Dieffenthaller
Journal for Immunotherapy of Cancer. 2023-12-11 - 16 citationsNatural killer cells for antiviral therapy.Davey M Smith, Jolie R Schafer, Brian Tullius, Laura Witkam, Silke Paust
Science Translational Medicine. 2023-01-04 - 38 citationsCRISPR Gene Editing of Human Primary NK and T Cells for Cancer Immunotherapy.Ezgi Elmas, Noushin Saljoughian, Marcelo de Souza Fernandes Pereira, Brian P Tullius, Kinnari Sorathia
Frontiers in Oncology. 2022-01-01
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: